Concord Biotech Limited
CONCORDBIO

Concord Biotech Limited

Pharmaceuticals
Share price
₹548
Market cap
₹11,474 Cr
1Y return
▼ 23%

An R&D-driven biopharma company engaged in manufacturing fermentation-based active pharmaceutical ingredients for immunosuppressants and oncology applications. Established in 1984, the company specializes in complex fermentation technology and serves domestic and international pharmaceutical markets with differentiated API solutions. Its focus on bioprocess innovation and vertical integration in fermentation-based manufacturing distinguishes it within the competitive global pharmaceutical ingredients landscape.

Investors holding Concord Biotech Limited

DSP Mutual Fund
DSP Mutual Fund
Mutual Fund
3.21%
2.68%
1.33%
SBI Mutual Fund
SBI Mutual Fund
Mutual Fund
1.06%

Recent moves 10

3moves in the last 30 days
Members only

Including 1 new position

Unlock all 3 moves
Tata AIA Life InsuranceIncreased
Tata AIA Life Insurance raised its stake in Concord Biotech from 2.48% to 2.68%, purchasing 2,14,980 shares.
17 Oct 2026
Read more
DSP Mutual FundIncreased
DSP Mutual Fund increased its stake in Concord Biotech from 1.75% to 3.21%. The fund raised its holding to 33,56,065 shares by acquiring 15,27,312 shares.
17 Oct 2026
Read more
SBI Mutual FundNew position
SBI Mutual Fund disclosed a 1.06% stake in Concord Biotech Limited, holding 11,07,121 shares as of the latest update. The fund previously held under 1% of the company.
17 Oct 2026
Read more
DSP Mutual FundNew position
DSP Mutual Fund bought 12,88,114 shares of Concord Biotech Limited for ₹180.86 Cr at ₹1404.10 apiece in a bulk deal.
31 Aug 2026
Read more
Government Pension Fund Global (Norway)Decreased
Government Pension Fund Global (Norway) decreased its stake in Concord Biotech Limited from 2.99% to 2.95%, selling 36,910 shares.
19 Jul 2026
Read more
Max Life InsuranceDecreased
Max Life Insurance decreased its stake in Concord Biotech Limited from 1.52% to 1.34%, selling 187,698 shares.
19 Jul 2026
Read more
Tata AIA Life InsuranceIncreased
Tata AIA Life Insurance increased its stake in Concord Biotech from 1.91% to 2.48% by purchasing 595,891 shares, bringing its total holdings to 2,590,472 shares.
19 Jul 2026
Read more

Track the whales in Concord Biotech Limited

Get alerted the moment a top investor buys or sells.

Start 7 days for ₹1Start for ₹29Try 7 days free